Search results for "Substance-Related Disorder"

showing 10 items of 141 documents

Transcranial Electrical and Magnetic Stimulation (tES and TMS) for Addiction Medicine: A Consensus Paper on the Present State of the Science and the …

2019

International audience; There is growing interest in non-invasive brain stimulation (NIBS) as a novel treatment option for substance-use disorders (SUDs). Recent momentum stems from a foundation of preclinical neuroscience demonstrating links between neural circuits and drug consuming behavior, as well as recent FDA-approval of NIBS treatments for mental health disorders that share overlapping pathology with SUDs. As with any emerging field, enthusiasm must be tempered by reason; lessons learned from the past should be prudently applied to future therapies. Here, an international ensemble of experts provides an overview of the state of transcranial-electrical (tES) and transcranial-magnetic…

Outcome Assessment[SDV]Life Sciences [q-bio]ReviewTranscranial Direct Current StimulationtDCSBehavioral Neuroscience0302 clinical medicineOutcome Assessment Health CarerTMSState of the sciencetEShealth care economics and organizationsmedia_commonCognitive sciencePsychiatryNIBS*tESNeuromodulation (medicine)3. Good healthSystematic reviewNeuropsychology and Physiological PsychologyPractice Guidelines as TopicPsychologyAddiction MedicineTranscranial electrical stimulationSubstance-Related DisordersSettore MED/12 - GASTROENTEROLOGIABest practicemedia_common.quotation_subjectCognitive NeuroscienceAddictionSubstance use disorderArticle03 medical and health sciences*Non-invasive brain stimulation*Transcranial magnetic stimulationHumansNon-invasive brain stimulation*Substance use disorderAddictionMental health*Addiction030227 psychiatry*NIBSHealth CareAddiction medicine*tDCSBrain stimulation*Transcranial electrical stimulation*Psychiatry*rTMS030217 neurology & neurosurgeryTranscranial magnetic stimulation
researchProduct

Norwegian health personnel’s compliance with new legislation on children of ill parents: an exploratory cross-sectional multicentre study

2022

Abstract Background In 2010 the Norwegian Parliament introduced amendments to the Health Personnel Act requiring all health personnel to inform and offer help to their patients’ children and families. We evaluated whether health personnel adhered to their obligations outlined in the Act and investigated whether family and health services characteristics were associated with the degree of compliance with the legislation. Our study was part of a larger Norwegian multi-site study conducted in five health trusts across Norway, assessing the situation for families living with parental illness. Method A cross-sectional study using quantitative data obtained from 518 patients 246 children and 278 …

ParentsCross-Sectional StudiesVDP::Medisinske Fag: 700::Helsefag: 800Child of Impaired ParentsNorwaySubstance-Related DisordersHealth PolicyHealth PersonnelHumansChild
researchProduct

Comparative neuroscience of stimulant-induced memory dysfunction: role for neurogenesis in the adult hippocampus.

2010

The discovery that the addictive drugs impair neurogenesis in the adult hippocampus has prompted the elaboration of new biological hypotheses to explain addiction and drug-induced cognitive dysfunction. Considerable evidence now implicates the process of adult neurogenesis in at least some critical components of hippocampal-dependent memory function. In experimental models, psychomotor stimulant drugs produce alterations in the rate of birth, survival, maturation and functional integration of adult-born hippocampal neurons. Thus some of the deleterious consequences of drug abuse on memory could result from the neurotoxic actions of drugs on adult hippocampal neurogenesis. In this review, we…

PharmacologyAdultMemory DisordersMemory DysfunctionWorking memorySubstance-Related DisordersDentate gyrusNeurogenesisNeurogenesisCognitive flexibilityHippocampusCognitionHippocampal formationHippocampusPsychiatry and Mental healthDentate GyrusAnimalsHumansCentral Nervous System StimulantsPsychologyCognition DisordersNeuroscienceBehavioural pharmacology
researchProduct

Infralow neurofeedback in the treatment of substance use disorders: a randomized controlled trial

2022

Background Infralow neurofeedback (ILF-NF) was recently developed as a subtype of traditional, frequency-based neurofeedback that targets cerebral rhythmic activity below 0.5 Hz and improves brain self-regulation. The efficacy of ILF-NF in the treatment of substance use disorder has not yet been evaluated, but clinical evidence suggests that it may prevent relapse by improving functioning in various life domains. The current study aimed to fill this research gap and extend empirical evidence related to this issue. Methods Ninety-three patients with substance use disorders at an outpatient unit in Norway were randomized to receive 20 sessions (30 minutes each) of ILF-NF training combined wit…

Psychiatry and Mental healthTreatment OutcomeVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Psykiatri barnepsykiatri: 757RecurrenceSubstance-Related DisordersQuality of LifeHumansPharmacology (medical)NeurofeedbackPsychomotor AgitationBiological PsychiatryJournal of Psychiatry and Neuroscience
researchProduct

2020

IntroductionSuccess rates of psychotherapy in post-traumatic stress disorder related to childhood maltreatment (PTSD-CM) are limited.Methods and analysisObserver-blind multicentre randomised clinical trial (A-1) of 4-year duration comparing enhanced methods of STAIR Narrative Therapy (SNT) and of trauma-focused psychodynamic therapy (TF-PDT) each of up to 24 sessions with each other and a minimal attention waiting list in PTSD-CM. Primary outcome is severity of PTSD (Clinician-Administered PTSD Scale for DSM-5 total) assessed by masked raters. For SNT and TF-PDT, both superiority and non-inferiority will be tested. Intention-to-treat analysis (primary) and per-protocol analysis (secondary).…

Psychodynamic psychotherapymedicine.medical_specialtybusiness.industryTraumatic stressSubstance-related disorderGeneral Medicinemedicine.diseaseInstitutional review boardlaw.inventionClinical trial03 medical and health sciences0302 clinical medicineDissociative identity disorderRandomized controlled triallawmedicine030212 general & internal medicinebusinessPsychiatryBorderline personality disorder030217 neurology & neurosurgeryBMJ Open
researchProduct

Quality of life improved following in-patient substance use disorder treatment

2015

Background Quality of life (QoL) is increasingly recognized as central to the broad construct of recovery in patients with substance use disorders (SUD). However, few longitudinal studies have evaluated changes in QoL after SUD treatment and included patients with SUD that were compulsorily hospitalized. This study aimed to describe QoL among in-patients admitted either voluntarily or compulsorily to hospitalization and to examine patterns and predictors of QoL at admission and at 6 months post treatment. Methods This prospective study followed 202 hospitalized patients with SUD that were admitted voluntarily (N=137) or compulsorily (N=65). A generic QoL questionnaire (QoL-5) was used to as…

Quality of lifeAdultMaleSubstance-Related DisordersResearchHealth StatusPublic Health Environmental and Occupational HealthSubstance use disorder treatmentTreatment outcomesCompulsory hospitalizationMiddle AgedhumanitiesSex FactorsTreatment OutcomeSurveys and QuestionnairesHumansFemaleLongitudinal StudiesProspective StudiesFollow-Up StudiesHealth and Quality of Life Outcomes
researchProduct

The quality of life when a partner has substance use problems: a scoping review

2018

Objective To examine the existing body of knowledge on quality of life (QoL) in partners of people with substance use problems (PP-SUPs) to provide a synthesized summary of the evidence and identify gaps in our knowledge on the QoL of PP-SUPs. Methods A systematic scoping review was performed. Publications indexed in EMBASE, Medline, PsycINFO, CINAHL, SocINDEX, and CENTRAL were searched for original, empirical, peer-reviewed, full-length research papers that examined QoL in PP-SUPs. Research papers identified through a manual search of key references and known references by co-authors were also included. A total of 3070 abstracts were screened, 41 full-text papers examined, and nine were fo…

Quality of lifeMaleSubstance-Related DisordersPopulationMEDLINE030508 substance abuseSubstance usesCINAHLPsycINFOReviewSubstance uselcsh:Computer applications to medicine. Medical informatics03 medical and health sciences0302 clinical medicineQuality of lifesubstance abusemedicineHumans030212 general & internal medicineeducationChildSpousesLife qualitiesQualitative Researcheducation.field_of_studyPublic Health Environmental and Occupational HealthGeneral Medicinemedicine.diseasehumanitiesPeer reviewSubstance abuselcsh:R858-859.7Female0305 other medical sciencePsychologyPartnersQualitative researchClinical psychologyHealth and Quality of Life Outcomes
researchProduct

Perceived family cohesion, social support, and quality of life in patients undergoing treatment for substance use disorders compared with patients wi…

2021

Abstract Purpose Support from family and other social network elements can be important in helping patients to cope with practical and emotional consequences of diseases. The aim of the study was to examine perception of family and social support and quality of life (QoL) in patients undergoing treatment for substance use disorders (SUDs). We compared them with patients in treatment for mental disorders (MDs) and physical disorders (PDs). Methods We used data from a national multicenter study that recruited patients (N  =  518) from three treatment domains; SUD treatment units, MD treatment units, and PD treatment units (severe neurological conditions or cancer). Data on family cohesion, so…

Quality of lifeMedicine (General)medicine.medical_specialtySubstance-Related Disorders030508 substance abuseSocial support03 medical and health sciencesSocial supportMental distressR5-9200302 clinical medicineSocial pathology. Social and public welfare. CriminologyQuality of lifeSurveys and QuestionnairesFamily cohesionAdaptation PsychologicalHumansMedicine030212 general & internal medicineCooperative BehaviorHV1-9960Substance use disordersVDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin sosialmedisin: 801Social networkSocial workNorwaybusiness.industryResearchPublic healthGeneral MedicinehumanitiesPeer reviewHealth psychology0305 other medical sciencebusinessClinical psychologyAddiction Science & Clinical Practice
researchProduct

Evolution of patients’ socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infecte…

2018

International audience; BACKGROUND:Direct-acting antivirals (DAA) have dramatically increased HCV cure rates with minimal toxicity in HIV-HCV co-infected patients. This study aimed to compare the socio-behavioral characteristics of patients initiating pegylated-interferon (PEG-IFN)-based HCV treatment with those of patients initiating DAA-based treatment.METHODS:ANRS CO13 HEPAVIH is a national multicenter prospective cohort started in 2005, which enrolled 1,859 HIV-HCV co-infected patients followed up in French hospital outpatient units. Both clinical/biological and socio-behavioral data were collected during follow-up. We selected patients with socio-behavioral data available before HCV tr…

RNA virusesMaleHealth BehaviorSocial Scienceslcsh:MedicineHIV InfectionsHepacivirusGeographical locationsChronic Liver Disease0302 clinical medicineRisk FactorsPrevalencePsychologyAlcohol consumptionProspective Studies030212 general & internal medicineYoung adultProspective cohort studylcsh:SciencePathology and laboratory medicinemedia_commonChronic hepatitisDrug injectionClinical Trials as TopicMultidisciplinarybiologyPharmaceuticsCoinfectionHepatitis C virusLiver Diseasesvirus diseasesMedical microbiologyMiddle AgedPrognosisHepatitis CAddicts3. Good healthEuropeBehavioral PharmacologyDrug usersVirusesCohortFemale030211 gastroenterology & hepatologyDrug therapyFrancePathogensResearch ArticleAdultDrugmedicine.medical_specialtySubstance-Related Disordersmedia_common.quotation_subjectLiver fibrosisAddictionContext (language use)Gastroenterology and HepatologyMicrobiologyAntiviral AgentsYoung Adult03 medical and health sciencesPharmacotherapyRecreational Drug UseInternal medicinemedicineHumansEuropean UnionNutritionAgedCannabisMedicine and health sciencesPharmacologyBiology and life sciencesFlavivirusesbusiness.industrylcsh:ROrganismsViral pathogensHIVbiology.organism_classificationHepatitis virusesdigestive system diseasesMicrobial pathogensDiet[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologielcsh:Q[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieCannabisPeople and placesbusiness
researchProduct

Targeting Homer genes using adeno-associated viral vector: lessons learned from behavioural and neurochemical studies.

2008

Over a decade of in-vitro data support a critical role for members of the Homer family of postsynaptic scaffolding proteins in regulating the functional architecture of glutamate synapses. Earlier studies of Homer knockout mice indicated a necessary role for Homer gene products in normal mesocorticolimbic glutamate transmission and behaviours associated therewith. The advent of adeno-associated viral vectors carrying cDNA for, or short hairpin RNA against, specific Homer isoforms enabled the site-directed targeting of Homers to neurons in the brain. This approach has allowed our groups to address developmental issues associated with conventional knockout mice, to confirm active roles for di…

Scaffold proteinSubstance-Related DisordersTransgeneEmotionsGenetic VectorsGlutamic AcidMice TransgenicBiologySynaptic TransmissionArticleViral vectorAdenoviridaeSmall hairpin RNAMiceNeurochemicalHomer Scaffolding ProteinsAnimalsGeneGenes Immediate-EarlyPharmacologyMice KnockoutBehavior AnimalGlutamate receptorGene Transfer TechniquesBrainPsychiatry and Mental healthAlcoholismKnockout mouseMutagenesis Site-DirectedArousalCarrier ProteinsNeuroscienceBehavioural pharmacology
researchProduct